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A Corrigendum on
An Overview of MicroRNAs as Biomarkers of ALS
by Joilin, G., Leigh, P. N., Newbury, S. F., and Hafezparast, M. (2019). Front. Neurol. 10:186.
doi: 10.3389/fneur.2019.00186
In the original article, there was a mistake in Table 1 as published. Some of the miRNAs listed
in the table were incorrectly placed in the wrong column and/or row. The corrected Table 1
appears below.
The authors apologize for this error and state that this does not change the scientific conclusions
of the article in any way. The original article has been updated.
Copyright © 2019 Joilin, Leigh, Newbury and Hafezparast. This is an open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
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TABLE 1 | Circulating miRNA-based biomarkers found to be differentially expressed in biofluids.
Authors ALS
type
n Validated changes Controls RNA
extraction
Profiling
technique
RT-qPCR
validation
RT-qPCR
Normalization
Increase Decrease
Serum Freischmidt
et al. (4)
Sporadic 22 – MIR132-5p
MIR132-3p
MIR143-5p
MIR143-3p
LET7B-5p
Age-matched
healthy controls
miRNeasyMini – Ncode VILO
EXPRESS
SYBRGreenER
Spiked
in cel-MIR39-3p
De Felice
et al. (5)
Sporadic 72 MIR338-3p – Age-matched
healthy controls
Trizol – miScript RT-
qPCR
LET7A
Freischmidt
et al. (6)
Familial 22 – MIR1825
MIR1915-3p
MIR3665
MIR4530
MIR4745-5p
Age-matched
healthy controls
QIAzol and
miRNeasyMini
Affymetrix
GeneChip
3.0 Array
miScript RT-
qPCR
Spiked
in cel-MIR39-3p
Sporadic 14 – MIR3665
MIR4530
MIR4745-5p
Toivonen
et al. (7)
– 12 MIR106B
MIR206
– Age-matched
healthy controls
Norgen
Total RNA
Affymetrix
GeneChip
2.0 Array
TaqMan
miRNA RT-
qPCR
Spiked
in cel-MIR39-3p
Freischmidt
et al. (8)
Sporadic 18 – MIR1234-3p
MIR1825
Age-matched
healthy controls/
Alzheimer’s/
Huntington’s
QIAzol and
miRNeasyMini
Affymetrix
GeneChip
3.0 Array
miScript RT-
qPCR
Spiked
in cel-MIR39-3p
Waller
et al. (13)
Sporadic 50 MIR143-3p
MIR206
MIR374B-5p Age-matched
healthy
controls/
diseasemimics
Norgen
Circulating
Nucleic
Acid Isolation
TaqMan Low
Density RT-
qPCR arrays
miScript RT-
qPCR
MIR17-5p
MIR24
MIR223-3p
Matamala
et al. (16)
Sporadic 20 MIR142-3p MIR1249-3p Age-matched
healthy controls
Trizol LS and
miRNeasy
Serum/
Plasma
Illumina
TruSeq Small
RNA on
IlluminaMiSeq
TaqMan
miRNA RT-
qPCR
Spiked
in cel-MIR39-3p
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TABLE 1 | Continued
Authors ALS
type
n Validated changes Controls RNA
extraction
Profiling
technique
RT-qPCR
validation
RT-qPCR
Normalization
Increase Decrease
Raheja
et al. (17)
Sporadic/
Familial
23 Screen only Screen only Healthy controls miRcury miRNA LNA
RT-
qPCR arrays
– –
Xu et al.
(18)
– 10 – MIR27A-3p Healthy controls Trizol or
miRNeasyMicro
– miDETECT A
Track miRNA
RT-qPCR or
TaqMan
miRNA RT-
qPCR
MIR16-5p
Plasma Takahashi
et al. (9)
Sporadic 48 MIR4649-5p MIR4299 Age-matched
healthy controls
miRNeasy Serum/
Plasma
3D-Gene
Human
miRNA
oligo chip
miScript RT-
qPCR
MIR4516
de
Andrade
et al. (11)
Sporadic 39 MIR424
MIR206
– Aged match
healthy control
miRVana PARIS Affymetrix
GeneChip
array
(on muscle)
TaqMan
miRNA RT-
qPCR
MIR16-5p
Sheinerman
et al. (12)
– 50 MIR206/MIR338-3p
MIR9/MIR129-3p
MIR335-
5p/MIR338-3p
Age-matched
healthy controls
Trizol and
Ambion Glass
fiber Columns
Literature search TaqMan
miRNA RT–
qPCR
–
Cerebrospinal
Fluid
Freischmidt
et al. (4)
Sporadic 22 MIR143-5p
MIR574-5p
MIR132-5p
MIR132-3p
MIR143-3p
Age-matched
healthy controls
miRNeasyMini – Ncode VILO
EXPRESS
SYBRGreenER
Spiked
in cel-MIR39-3p
De Felice
et al. (5)
Sporadic 72 MIR338-3p – Age-matched
healthy controls
Trizol – miScript RT-
qPCR
MIR24
Benigni
et al. (10)
Sporadic 24 MIR181A-5p LET7A-5p
LET7B-5p
LET7F-5p
MIR15b-5p
MIR21-5p
MIR195-5p
MIR148A-3p
Age-matched
healthy controls
miRNeasyMini Human
miFinder
384HC
miRNA
PCR array
SYBR
Green RT-
qPCR
Spiked in
cel-MIR39-3p
MIR608MIR328-
3p
Waller
et al. (14)
Sporadic 32 Screen only Screen only Age-matched
healthy
controls/diseasemimics
miRVana PARIS Illumina
TruSeq Small
RNA on
Illumina HiScanSq
miScript
II RT-qPCR
Spiked in
cel-MIR39-
3p MIR30A-5p
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TABLE 1 | Continued
Authors ALS
type
n Validated changes Controls RNA
extraction
Profiling
technique
RT-qPCR
validation
RT-qPCR
Normalization
Increase Decrease
Whole Blood Liguori
et al. (15)
Sporadic 56 - LET7A-5p
LET7D-5p
LET7F-5p
LET7G-5p
LET7I-5p
MIR15A-5p
MIR15B-5p
MIR151A-5p
MIR151B
MIR16-5p
MIR22-3p
MIR23A-3p
MIR26A-5p
MIR26B-5p
MIR27B-3p
MIR28-3p
MIR30B-5p
MIR30C-5p
MIR93-5p
MIR103A-3p
MIR106B-3p
MIR128-3p
MIR130A-3p
MIR130B-3p
MIR144-5p
MIR148A-3p
MIR148B-3p
MIR182-5p
MIR183-5p
MIR186-5p
MIR221-3p
MIR223-3p
MIR342-3p
MIR425-5p
MIR451A
MIR532-5p
MIR550A-3p
MIR584-5p
Age-matched
healthy controls
PAXgene
Blood RNA
Illumina
TruSeq Small
RNA on
Illumina HiSeq2500
TaqMan
Advanced
miRNA RT-
qPCR
MIR484
Those miRNA underlined show consistent directional changes between control and ALS cases while those in bold show contrasting directional changes between control and ALS cases.
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